Giorgia Marisi

Statistics

Publications

Citations

1.6K

H-Index

Active since

2014

Affiliations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Cagliari

University of Modena and Reggio Emilia

University of Bologna

Giorgia Marisi is an author at Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori specializing in oncology, medicine, and sorafenib therapy.

ORCID

Publications per year

2014–2025

Publications

In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3–Mediated Apoptosis

Francesca Fornari, Daniela Pollutri, Clarissa Patrizi et al. · Clinical Cancer Research · 2017 · 172 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

Andrea Casadei‐Gardini, Emanuela Scarpi, Luca Faloppi et al. · Oncotarget · 2016 · 94 citations · Full text

Medicine, Immunology, Oncology +17

Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale

Andrea Casadei‐Gardini, Luca Faloppi, Serena De Matteis et al. · European Journal of Cancer · 2017 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer

Paola Ulivi, Matteo Canale, Alessandro Passardi et al. · International Journal of Molecular Sciences · 2018 · 74 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib

Andrea Casadei‐Gardini, Giorgia Marisi, Emanuela Scarpi et al. · Expert Opinion on Pharmacotherapy · 2015 · 72 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

1–5 of 43